Back to HAE overview

HAE Haemonetics PE ratio, current and historical analysis

As of Jun 12, 2024, the HAE stock has a PE ratio of 37.04. The calculation is based on the latest EPS of $2.32 and the stock price of $85.93 per share. An increase of 7% has been observed in the PE ratio compared to its average of 34.5 of the last four quarters.

HAE PE ratio history

How has HAE's PE ratio performed in the past

The mean historical PE ratio of Haemonetics over the last ten years is 110.43. The current 37.04 P/E ratio is 66% lower than the historical average. Looking back at the last ten years, HAE's PE ratio peaked in the Sep 2017 quarter at 641, with a price of $44.87 and an EPS of $0.07. The Jul 2023 quarter marked the lowest point at 31.65, with a price of $85.14 and an EPS of $2.69.

Average
110.43
Median
70.03
Minimum
31.65
Maximum
641

Haemonetics PE ratio by year

Maximum annual increase: 183.71% in 2015

Maximum annual decrease: -51.48% in 2023

Year PE ratio Change
2024 36.79 0.93%
2023 36.45 -51.48%
2022 75.12 5.27%
2021 71.36 6.75%
2020 66.85 -18.24%
2019 81.76 -3.89%
2018 85.07 N/A
2017 N/A N/A
2016 N/A N/A
2015 133.97 183.71%

HAE average PE ratio chart

What is the average PE ratio of HAE for the past years

The current PE ratio of HAE is lower than its 3, 5 and 10-year averages.

3-year avg
56.7
5-year avg
62.69
10-year avg
110.43
15-year avg
82.79

HAE PE vs peers

What is HAE's PE ratio compared to its peers

In comparison to its peers SYK and BDX, HAE's PE ratio is lower, but it is higher than JNJ's and TMO's. Haemonetics's PE ratio is trading above the peer average of 28.25.

Stock name PE ratio Market cap
BAX Baxter International Inc 6.45 $17.19B
JNJ Johnson & Johnson 9.53 $350.05B
MDT Medtronic plc 25.92 $108.43B
TMO Thermo Fisher Scientific Inc 36.59 $218.58B
HAE Haemonetics Corp 37.09 $4.37B
SYK Stryker Corp 38.76 $130.67B
BDX Becton Dickinson & Co 51.09 $67.04B
CERS Cerus Corp N/A $332.8M

Frequently asked questions

What is Haemonetics's PE ratio?

As of Jun 12, 2024, HAE stock has a price to earnings ratio of 37.04.

What is the 3-year average PE ratio for Haemonetics (HAE)?

The 3-year average price to earnings ratio for HAE stock is 56.7.

What is the 5-year average PE ratio for Haemonetics (HAE)?

The 5-year average price to earnings ratio for HAE stock is 62.69.

What is the highest PE ratio for HAE?

Over the last ten years, the quarterly PE ratio reached its highest level at 641 in the Sep 2017 quarter.

How does the current PE ratio for HAE compare to its historical average?

HAE's current price to earnings ratio is 66% below its 10-year historical average.

How is HAE's PE ratio calculated (Haemonetics PE ratio formula)?

To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Jun 12, 2024), Haemonetics's share price is $85.93. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2024 is $2.32. Therefore, Haemonetics's PE ratio for today is 37.04. PE RATIO(37.04) = STOCK PRICE($85.93) / TTM EPS($2.32)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.